Journal of Inherited Metabolic Disease

, Volume 16, Issue 2, pp 161–170 | Cite as

Introduction to the age-related diagnosis (ARD) index: an age at presentation related index for diagnostic use

  • R. A. Harkness
  • E. J. Harkness
Article
  • 31 Downloads

Summary

Development and, therefore, age is important in paediatrics. Diagnostically useful data from this journal has been related to age and organized to form an age-related diagnostic (ARD) index. The ARD index is designed for non-expert clinical and laboratory workers to use in the early phases of diagnosis and as an addition to existing diagnostic schemes. Entry to the index is from the age at clinical presentation. Each entry is a sequence starting with clinical and laboratory presentations, clinical course, laboratory key investigations and finally diagnosis with volume and page numbers of the original article, the primary source. Within age groups, entries are grouped by diagnoses with the commonest diagnosis first; this has the effect of roughly but not precisely grouping similar clinical and laboratory findings.

Keywords

Public Health Internal Medicine Early Phase Primary Source Laboratory Finding 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams A, Harkness RA (1976) Developmental changes in purine phosphoribosyltransferases in human and rat tissues.Biochem J 160: 565–576.Google Scholar
  2. Association of Clinical Biochemists (1983) Proposals for a coordinated scheme for the postnatal diagnosis of inherited metabolic disease in infancy.Association of Clinical Biochemists News Sheet 237: 6–12.Google Scholar
  3. Astion ML, Wilding P (1992) Application of neural networks to the interpretation of laboratory data in cancer diagnosis.Clin Chem 38: 34–38.Google Scholar
  4. Bachmann C (1992) Ornithine carbamoyltransferase deficiency: findings, models and problems.J Inher Metab Dis 15: 578–591.Google Scholar
  5. Bakkeren JAJ, Sengers RCS, Trijbels JMF, Engels PHATh (1977) Organic aciduria in hypoxic premature newborns simulating an inborn error of metabolism.Eur J Pediatr 127: 41–47.Google Scholar
  6. Brown GK (1992) Pyruvate dehydrogenase E1α deficiency.J Inher Metab Dis 15: 625–633.Google Scholar
  7. Chalmers RA, Purkiss P, Watts RWE, Lawson AM (1980) Screening for organic acidurias and aminoacidopathies in newborn and children.J Inher Metab Dis 3: 27–43.Google Scholar
  8. Chalmers RA, Watts RWE (1969) The separate determination of xanthine and hypoxanthine in urine and blood plasma by an enzymatic differential spectrophotometric method.Analyst 94: 226–233.Google Scholar
  9. Cohen HJ, Johnson JL, Rajagopalan DKV (1974) Molecular basis of the biological function of molybdenum. Developmental patterns of sulfite oxidase and xanthine oxidase in the rat.Arch Biochem Biophys 164: 440–446.Google Scholar
  10. Cohn RM, Roth KS (1983)Metabolic Disease, A Guide to Early Recognition. Philadelphia: WB Saunders.Google Scholar
  11. Cusworth DC (1980) A computer based index of metabolic diseases.J Inher Metab Dis 3: 81–82.Google Scholar
  12. Green A, Hall SM (1992) Investigation of metabolic disorders resembling Reye's syndrome.Arch Dis Childh 67: 1313–1317.Google Scholar
  13. Goldberg RN, Caval LA, Sinatra FR, Plajstek CE, Hodgman JE (1979) Hyperammonemia associated with perinatal asphyxia.Pediatrics 64: 336–341.Google Scholar
  14. Hallman M (1971) Changes in mitochondrial respiratory chain proteins during perinatal development. Evidence of the importance of environmental oxygen tension.Biochim Biophys Acta 253: 360–372.Google Scholar
  15. Harkness RA (1987) Clinical biochemistry of the neonatal period: immaturity, hypoxia and metabolic disease.J Clin Pathol 40: 1128–1144Google Scholar
  16. Harkness RA, Lind RJ (1983) Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia.J Clin Pathol 36: 1–8.Google Scholar
  17. Kornberg A (1991) Understanding life as chemistry.Clin Chem 37: 1895–1899.Google Scholar
  18. Laing I, Brown JK, Harkness RA (1988) Clinical and biochemical assessments of damage due to perinatal asphyxia: a double blind trial of a quantitative method.J Clin Pathol 441: 247–252.Google Scholar
  19. Levin SD, Brown JK, Harkness RA (1984) Cerebrospinal fluid hypoxanthine and xanthine as indicators of metabolic damage due to raised intracranial pressure in hydrocephalic children.J Neurol Neurosurg Psychiatr 47: 730–733.Google Scholar
  20. Lewin B (1990)Genes IV. Oxford University Press.Google Scholar
  21. Low JA, Simpson LI, Ramsey DA (1992) The clinical diagnosis of asyphyxia responsible for brain damage in the human fetus.Am J Obstet Gynecol 167: 11–15.Google Scholar
  22. Marlow N (1992) Do we need an APGAR score?Arch Dis Childh 67: 765–767.Google Scholar
  23. Meberg A, Saugstad OD (1978) Hypoxanthine in cerebrospinal fluid in children.Scand J Clin Lab Invest 38: 437–440.Google Scholar
  24. Newell SJ, Green SH (1987) Diagnostic classification of the aetiology of mental retardation in children.Br Med J 294: 163–166.Google Scholar
  25. O'Connor MC, Harkness RA, Simmonds RJ, Hytten FE (1982) Raised hypoxanthine and uridine concentrations in meconium stained amniotic fluid and during labour.Br J Obstet Gynaecol 88: 375–380.Google Scholar
  26. Paneth N, Stark RI (1983) Cerebral palsy and mental retardation in relation to indicators of perinatal asphyxia. An epidemiological overview.Am J Obstet Gynecol 147: 960–966.Google Scholar
  27. Raiha NCR, Suihkonen J (1968) Factors influencing the development of urea synthesising enzymes in the rat.Biochem J 107: 793–797.Google Scholar
  28. Reynolds AP, Harkness RA (1991) Urinary thiosulphate/creatinine concentration ratio in hospitalized children.J Inher Metab Dis 14: 938–939.Google Scholar
  29. Saudubray JM et al (1989) Clinical approach to inherited metabolic diseases in the neonatal period: A 20-year survey.J Inher Metab Dis 12: Suppl 1: 25–41.Google Scholar
  30. Schimke RT (1962) Adaptive characteristics of urea cycle enzymes in the rat.J Biol Chem 237: 459–468.Google Scholar
  31. Stanley FJ (1987) The changing face of cerebral palsy.Devel Med Child Neurol 29: 258–270.Google Scholar
  32. Stevenson DK et al (1986) Increased immunoreactive erythropoetin in cord plasma and neonatal bilirubin production in normal term infants after labour.Obstet Gynecol 67: 69–73.Google Scholar
  33. Swank RT et al (1978) Genetic regulation of mammalian β-glucuronidase.Rec Progr Horm Res 34: 401–436.Google Scholar
  34. Touma EH, Charpentier C (1992) Medium chain acyl-CoA dehydrogenase deficiency.Arch Dis Childh 67: 142–145.Google Scholar
  35. Waheed A, Haslik A, von Figura K (1982) Enhanced breakdown of arylsulfatase A in multiple sulfatase deficiency.Eur J Biochem 123: 317–321.Google Scholar
  36. Walter JH (1992) Metabolic acidosis in newborn infants.Arch Dis Childh 67: 767–769.Google Scholar
  37. Winter RM, Baraitser M, Douglas JM (1984) A computerised data base for the diagnosis of rare dysmorphic syndromes.J Med Genet 21: 121–123.Google Scholar
  38. Yeung D, Oliver IT (1967) Development of gluconeogenesis in neonatal rat liver.Biochem J 105: 1229–1233.Google Scholar

Copyright information

© Society for the Study of Inborn Errors of Metabolism and Kluwer Academic Publishers 1993

Authors and Affiliations

  • R. A. Harkness
    • 1
  • E. J. Harkness
    • 1
  1. 1.Hatch EndPinnerUK

Personalised recommendations